Kirk Beebe, Director of Application Science at Metabolon, presented at the Cell Culture World Congress USA 2013. Enclosed are his presentation slides from the event, where he addresses employing metabolomics in cell culture and bioprocessing to gain greater predictability, control and quality.
You can now view the recording of his presentation alongside these slides, so that you can both hear his presentation and view the slides he’s referring to up close. After all, we wouldn’t want you to miss anything, right?
Metabolon is a diagnostics and services company offering the industry’s leading biochemical profiling platform. Our patented platform provides a global analysis of complex biological samples for the discovery of markers and pathways associated with drug action and disease. This metabolomics-driven approach enables the identification of biomarkers useful for the development of a wide range of diagnostics and provides insight into complex biochemical processes such as drug action, toxicology and bioprocess optimization.
During his presentation, Kirk addresses:
- Major drivers of the “black box”
This year’s event will take place September 15-16 in Boston, MA and will feature expert speakers from MedImmune, the FDA, the University of Toronto, Merck, and more. Hope to see you there!